OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV Therapy
Francesco Negro
Cold Spring Harbor Perspectives in Medicine (2019) Vol. 10, Iss. 4, pp. a036921-a036921
Open Access | Times Cited: 26
Francesco Negro
Cold Spring Harbor Perspectives in Medicine (2019) Vol. 10, Iss. 4, pp. a036921-a036921
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Risk of hepatocellular carcinoma after hepatitis C virus cure
Maria Alejandra Luna‐Cuadros, Hao‐Wei Chen, Hira Hanif, et al.
World Journal of Gastroenterology (2021) Vol. 28, Iss. 1, pp. 96-107
Open Access | Times Cited: 40
Maria Alejandra Luna‐Cuadros, Hao‐Wei Chen, Hira Hanif, et al.
World Journal of Gastroenterology (2021) Vol. 28, Iss. 1, pp. 96-107
Open Access | Times Cited: 40
Towards an HCV vaccine: an overview of the immunization strategies for eliciting an effective B-cell response
G L Costa, Giuseppe A. Sautto
Expert Review of Vaccines (2025)
Open Access
G L Costa, Giuseppe A. Sautto
Expert Review of Vaccines (2025)
Open Access
Frequency of Hepatitis B Virus and Hepatitis C Virus Infection in Beta Thalassemia Major Children in Tertiary Care Hospital
Warisha Altaf, Maqbool Hussain
Indus journal of bioscience research. (2025) Vol. 3, Iss. 1, pp. 444-448
Closed Access
Warisha Altaf, Maqbool Hussain
Indus journal of bioscience research. (2025) Vol. 3, Iss. 1, pp. 444-448
Closed Access
Treatment of chronic hepatitis C infection: strategies to address poor therapy adherence
Robert Flisiak, Piotr Rzymski, Marta Flisiak‐Jackiewicz, et al.
Expert Review of Anti-infective Therapy (2025), pp. 1-9
Closed Access
Robert Flisiak, Piotr Rzymski, Marta Flisiak‐Jackiewicz, et al.
Expert Review of Anti-infective Therapy (2025), pp. 1-9
Closed Access
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Exploring Systemic Impacts and Innovative Therapies
Parag Jain, Akanksha Jain, Rohitas Deshmukh, et al.
Clinics and Research in Hepatology and Gastroenterology (2025), pp. 102584-102584
Closed Access
Parag Jain, Akanksha Jain, Rohitas Deshmukh, et al.
Clinics and Research in Hepatology and Gastroenterology (2025), pp. 102584-102584
Closed Access
Hepatitis C testing and linkage to care in a safety-net hospital emergency department
Nicole Lue, Jennifer Lom, Elizabeth Manguso, et al.
The American Journal of Emergency Medicine (2025)
Closed Access
Nicole Lue, Jennifer Lom, Elizabeth Manguso, et al.
The American Journal of Emergency Medicine (2025)
Closed Access
Adaptive Immune Response against Hepatitis C Virus
Janine Kemming, Robert Thimme, Christoph Neumann‐Haefelin
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5644-5644
Open Access | Times Cited: 27
Janine Kemming, Robert Thimme, Christoph Neumann‐Haefelin
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5644-5644
Open Access | Times Cited: 27
The Role of the Microbiota Gut–Liver Axis during HCV Chronic Infection: A Schematic Overview
Nadia Marascio, Carmen De, Angela Quirino, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5936-5936
Open Access | Times Cited: 14
Nadia Marascio, Carmen De, Angela Quirino, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5936-5936
Open Access | Times Cited: 14
The curing regimens of HCV: A SWOT analysis
Markus Cornberg, Michael P. Manns
Antiviral Therapy (2022) Vol. 27, Iss. 2, pp. 135965352110726-135965352110726
Open Access | Times Cited: 13
Markus Cornberg, Michael P. Manns
Antiviral Therapy (2022) Vol. 27, Iss. 2, pp. 135965352110726-135965352110726
Open Access | Times Cited: 13
Hepatitis C Virus
David E. Kaplan
Annals of Internal Medicine (2020) Vol. 173, Iss. 5, pp. ITC33-ITC48
Closed Access | Times Cited: 19
David E. Kaplan
Annals of Internal Medicine (2020) Vol. 173, Iss. 5, pp. ITC33-ITC48
Closed Access | Times Cited: 19
Personalized care approaches to hepatitis C therapy: recent advances and future directions
Nicola Schiano Moriello, Biagio Pinchera, Ivan Gentile
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 4, pp. 139-151
Closed Access | Times Cited: 2
Nicola Schiano Moriello, Biagio Pinchera, Ivan Gentile
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 4, pp. 139-151
Closed Access | Times Cited: 2
Protein Induced by Vitamin K Absence or Antagonist-II Versus Alpha-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
Abdallah Kobeissy, Nooraldin Merza, Alsadiq Al‐Hillan, et al.
Journal of Clinical Medicine Research (2023) Vol. 15, Iss. 7, pp. 343-359
Open Access | Times Cited: 6
Abdallah Kobeissy, Nooraldin Merza, Alsadiq Al‐Hillan, et al.
Journal of Clinical Medicine Research (2023) Vol. 15, Iss. 7, pp. 343-359
Open Access | Times Cited: 6
Immune Activation Induces Telomeric DNA Damage and Promotes Short‐Lived Effector T Cell Differentiation in Chronic HCV Infection
Lam Nhat Nguyen, Lam Ngoc Thao Nguyen, Juan Zhao, et al.
Hepatology (2021) Vol. 74, Iss. 5, pp. 2380-2394
Open Access | Times Cited: 14
Lam Nhat Nguyen, Lam Ngoc Thao Nguyen, Juan Zhao, et al.
Hepatology (2021) Vol. 74, Iss. 5, pp. 2380-2394
Open Access | Times Cited: 14
Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy
Meritxell Llorens-Revull, María Isabel Costafreda, Angie Rico, et al.
PLoS ONE (2021) Vol. 16, Iss. 7, pp. e0254243-e0254243
Open Access | Times Cited: 14
Meritxell Llorens-Revull, María Isabel Costafreda, Angie Rico, et al.
PLoS ONE (2021) Vol. 16, Iss. 7, pp. e0254243-e0254243
Open Access | Times Cited: 14
Hepatitis C Virus: History and Current Knowledge
Skënder Topi, Elona Gaxhja, Ioannis Alexandros Charitos, et al.
Gastroenterology Insights (2024) Vol. 15, Iss. 3, pp. 676-707
Open Access | Times Cited: 1
Skënder Topi, Elona Gaxhja, Ioannis Alexandros Charitos, et al.
Gastroenterology Insights (2024) Vol. 15, Iss. 3, pp. 676-707
Open Access | Times Cited: 1
Direct antiviral agents in hepatitis C virus related liver disease: Don’t count the chickens before they’re hatched
Stella Compagnoni, Erica Maria Bruno, Giorgio Madonia, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 21, pp. 2771-2783
Open Access | Times Cited: 7
Stella Compagnoni, Erica Maria Bruno, Giorgio Madonia, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 21, pp. 2771-2783
Open Access | Times Cited: 7
Unrevealing the challenge of perinatal transmission and risk factors of Hepatitis C virus infection in India: a review
Swati Sharma, R.V. Bhavani, Kamal Singh
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
Swati Sharma, R.V. Bhavani, Kamal Singh
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
Effectiveness of Ledipasvir-Sofosbuvir 12 Weeks After Hepatitis C Virus Genotype 1 Infection and the Factors Associated With Sustained Virologic Response: A Retrospective Study
Ismaeel Alshoaibi, Abdullah H. AL-Gamli, Mohammed Abdullah, et al.
Cureus (2024)
Open Access
Ismaeel Alshoaibi, Abdullah H. AL-Gamli, Mohammed Abdullah, et al.
Cureus (2024)
Open Access
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?
Carlo Smirne, Maria Grazia Crobu, Irene Landi, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1899-1899
Open Access
Carlo Smirne, Maria Grazia Crobu, Irene Landi, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1899-1899
Open Access
Hepatitis C: Exploration of Diseases, Diagnosis, and Treatment Strategies
Laiba Masood, Nayyer Islam, Muhammad Irfan, et al.
Springer eBooks (2023), pp. 331-348
Closed Access | Times Cited: 1
Laiba Masood, Nayyer Islam, Muhammad Irfan, et al.
Springer eBooks (2023), pp. 331-348
Closed Access | Times Cited: 1
Prevalence of hepatitis C, hepatitis B and HIV and their therapeutic management in a French public psychiatric hospital
Foulques Icole, Vincent Haghnejad, Cyrille Jeannoel, et al.
L Encéphale (2024)
Closed Access
Foulques Icole, Vincent Haghnejad, Cyrille Jeannoel, et al.
L Encéphale (2024)
Closed Access
Chronic hepatitis C in hemodialysis patients: Prevalence and liver fibrosis impact in the National Center for Renal Health in Peru
Martín Padilla, Eduardo Luna-Victoria, Ada Cabrera, et al.
iLiver (2022) Vol. 1, Iss. 3, pp. 141-144
Open Access | Times Cited: 1
Martín Padilla, Eduardo Luna-Victoria, Ada Cabrera, et al.
iLiver (2022) Vol. 1, Iss. 3, pp. 141-144
Open Access | Times Cited: 1
A IMPOSSIBILIDADE DO TRATAMENTO FARMACOLÓGICO PARA HEPATITE C CRÔNICA DEVIDO À INTERAÇÕES MEDICAMENTOSAS
Érica da Silva Anselmo, Ana Paula Schermack, Líncon Bordignon Somensi, et al.
Revista Contemporânea (2023) Vol. 3, Iss. 6, pp. 5665-5684
Open Access
Érica da Silva Anselmo, Ana Paula Schermack, Líncon Bordignon Somensi, et al.
Revista Contemporânea (2023) Vol. 3, Iss. 6, pp. 5665-5684
Open Access
Efetividade, segurança e dinâmica de seleção de mutações de resistência envolvendo o uso de fármacos de ação direta na infecção crônica pelo genótipo 3 do HCV
João Paulo Vilela Rodrigues
(2023)
Open Access
João Paulo Vilela Rodrigues
(2023)
Open Access
Hepatitis C Virus Infection: Epidemiological, Diagnostic and Therapeutic Aspects at the Departmental and Teaching Hospital of Borgou-Alibori
K Saké, Attinsounon CA, Kpossou AR, et al.
Austin Journal of Infectious Diseases (2023) Vol. 10, Iss. 3
Open Access
K Saké, Attinsounon CA, Kpossou AR, et al.
Austin Journal of Infectious Diseases (2023) Vol. 10, Iss. 3
Open Access
